CellaVision AB (publ)
CLVSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.02 | -3.14 | 23.90 | 1.29 |
| FCF Yield | 0.17% | 0.77% | 0.87% | 0.31% |
| EV / EBITDA | 105.80 | 80.83 | 77.18 | 105.20 |
| Quality | ||||
| ROIC | 3.29% | 4.22% | 4.81% | 4.45% |
| Gross Margin | 69.07% | 67.72% | 70.44% | 69.19% |
| Cash Conversion Ratio | 0.76 | 1.21 | 1.17 | 0.89 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.97% | 7.67% | 6.68% | 4.19% |
| Free Cash Flow Growth | -77.65% | -17.00% | 91.86% | -14.44% |
| Safety | ||||
| Net Debt / EBITDA | -3.32 | -2.40 | -2.76 | -1.92 |
| Interest Coverage | 100.11 | 12.16 | 10.93 | 18.75 |
| Efficiency | ||||
| Inventory Turnover | 0.48 | 0.53 | 0.48 | 0.46 |
| Cash Conversion Cycle | 197.66 | 171.16 | 184.31 | 205.29 |